Wegovy Is Available Again After Shortages, FDA Says—But Supplies Are Still Limited
Booming demand for weight loss and diabetes drugs like Ozempic, Wegovy, Mounjaro and Zepbound has vastly outpaced Novo Nordisk and Eli Lilly’s ability to produce the medication and supplies of smaller doses have been limited for months.
Booming demand for weight loss and diabetes drugs like Ozempic, Wegovy, Mounjaro and Zepbound has vastly outpaced Novo Nordisk and Eli Lilly’s ability to produce the medication and supplies of smaller doses have been limited for months.
What's Your Reaction?
